Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer.
Where this comes from
- Record sourced from PubMed, PMID 27211932.
- Also identified by DOI 10.1016/j.athoracsur.2016.02.086.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Shared decision making is a dynamic clinical process by which the provider assists the patient in choosing between more than one treatment option for a given condition. Here, we explore what the shared decision making and risk communication process could look like in the setting of a high-risk patient with clinical stage I non-small cell lung cancer who is potentially eligible for either segmentectomy or stereotactic body radiation therapy. We highlight clinical tools that can be used during the shared decision making and risk communication process in a stepwise manner to identify patient preferences and values to assist in making a tailored treatment decision.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Decision Making
- Informed Consent
- Lung Neoplasms
- Physician-Patient Relations